Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Transplantation

  Free Subscription

Articles published in Transpl Int

Retrieve available abstracts of 106 articles:
HTML format

Single Articles

    November 2021
  1. ORCI LA, Combescure C, Fink M, Oldani G, et al
    Predicting recurrence of hepatocellular carcinoma after liver transplantation using a novel model that incorporates tumor and donor-related factors.
    Transpl Int. 2021 Nov 16. doi: 10.1111/tri.14161.
    PubMed     Abstract available

  2. ABERG F, Abrahamsson J, Schult A, Bennet W, et al
    The RETREAT score provides valid predictions regarding hepatocellular carcinoma recurrence after liver transplantation.
    Transpl Int. 2021 Nov 14. doi: 10.1111/tri.14159.
    PubMed     Abstract available

  3. SNEIDERS D, van Dijk ARM, Polak WG, Mirza DF, et al
    Full-left-full-right split liver transplantation for adult recipients: A systematic review and meta-analysis.
    Transpl Int. 2021 Nov 13. doi: 10.1111/tri.14160.
    PubMed     Abstract available

  4. TEO VXY, Heng RRY, Tay PWL, Ng CH, et al
    A Meta-Analysis on the Prevalence of Chronic Kidney Disease in Liver Transplant Candidates and its Associated Risk Factors and Outcomes.
    Transpl Int. 2021 Nov 13. doi: 10.1111/tri.14158.
    PubMed     Abstract available

  5. LIN J, Ko CJ, Lin KH, Hung YJ, et al
    The Glissonian Stitch Traction for Biliary Duct Manipulation in Living Donor Liver Transplantation.
    Transpl Int. 2021 Nov 8. doi: 10.1111/tri.14155.
    PubMed     Abstract available

  6. BHANJI RA, Chow J, Ma M, Pannu N, et al
    Post liver transplantation chronic kidney disease is associated with increased cardiovascular disease risk and poor survival.
    Transpl Int. 2021 Nov 5. doi: 10.1111/tri.14154.
    PubMed     Abstract available

  7. NUTU OA, Sneiders D, Mirza D, Isaac J, et al
    Safety of intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma, a propensity-score matched survival analysis.
    Transpl Int. 2021 Nov 1. doi: 10.1111/tri.14150.
    PubMed     Abstract available

  8. DUELAND S, Smedman TM, Rosok B, Grut H, et al
    Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases.
    Transpl Int. 2021;34:2205-2213.
    PubMed     Abstract available

    October 2021
  9. LIM SY, Wang R, Tan DJH, Ng CH, et al
    A Meta-Analysis of the Cumulative Incidence, Risk Factors, and Clinical Outcomes associated with Chronic Kidney Disease after Liver Transplantation.
    Transpl Int. 2021 Oct 29. doi: 10.1111/tri.14149.
    PubMed     Abstract available

    September 2021
  10. YUAN Q, Haque O, Yeh H, Markmann JF, et al
    The impact of race and comorbid conditions on adult liver transplant outcomes in obese recipients.
    Transpl Int. 2021 Sep 27. doi: 10.1111/tri.14125.
    PubMed     Abstract available

  11. IVANICS T, Leonard-Murali S, Mouzaihem H, Moonka D, et al
    Extreme Hyponatremia as a Risk Factor for Early Mortality after Liver Transplantation in the MELD-Sodium Era.
    Transpl Int. 2021 Sep 27. doi: 10.1111/tri.14123.
    PubMed     Abstract available

  12. ANDRES A, Sapisochin G, Nadalin S, Adam R, et al
    Liver transplantation for colorectal liver metastasis: aiming for a cure or a palliation?
    Transpl Int. 2021 Sep 7. doi: 10.1111/tri.14032.
    PubMed     Abstract available

  13. BRIGGS G, Wallace D, Flasche S, Walker K, et al
    Inferior outcomes in young adults undergoing liver transplantation - A UK & ireland cohort study.
    Transpl Int. 2021 Sep 6. doi: 10.1111/tri.14033.
    PubMed     Abstract available

  14. CENTONZE L, Di Sandro S, Lauterio A, De Carlis R, et al
    A retrospective single-centre analysis of the oncological impact of LI-RADS classification applied to Metroticket 2.0 calculator in liver transplantation: every nodule matters.
    Transpl Int. 2021;34:1712-1721.
    PubMed     Abstract available

  15. LANARI J, Hagness M, Sartori A, Rosso E, et al
    Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score.
    Transpl Int. 2021;34:1722-1732.
    PubMed     Abstract available

  16. DE STEFANO N, Navarro-Tableros V, Roggio D, Calleri A, et al
    Human liver stem cell-derived extracellular vesicles reduce injury in a model of normothermic machine perfusion of rat livers previously exposed to a prolonged warm ischemia.
    Transpl Int. 2021;34:1607-1617.
    PubMed     Abstract available

    August 2021
  17. BEKKI Y, Von Ahrens D
    The long-term outcomes in liver transplantation using donation after circulatory death grafts.
    Transpl Int. 2021 Aug 21. doi: 10.1111/tri.14023.
    PubMed     Abstract available

  18. TSIEN C, Selzner N
    PSC Recurrence Post Liver Transplantation: Re-Transplantation justified or not?
    Transpl Int. 2021 Aug 19. doi: 10.1111/tri.14014.
    PubMed     Abstract available

  19. GROTTENTHALER JM, Konzelmann A, Stiegler A, Hinterleitner C, et al
    Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation - development of a risk score.
    Transpl Int. 2021 Aug 6. doi: 10.1111/tri.14007.
    PubMed     Abstract available

  20. CABALLERO-MARCOS A, Romero-Cristobal M, Puerto M, Fernandez-Yunquera A, et al
    HCV Eradication in Recurrent Hepatitis C after Liver Transplantation Normalizes Enhanced Endothelial Activation.
    Transpl Int. 2021 Aug 3. doi: 10.1111/tri.14000.
    PubMed     Abstract available

    July 2021
  21. PERETZ D, On NH, Miller D, Kim R, et al
    Pharmacokinetics of a Once Daily Tacrolimus Formulation in First Nations and Caucasian Liver Transplant Recipients.
    Transpl Int. 2021 Jul 28. doi: 10.1111/tri.13997.
    PubMed     Abstract available

  22. NG CH, Lim WH, Lim XC, Xiao J, et al
    A Meta-Analysis on the Incidence of Donor Related Depression after Liver Transplant.
    Transpl Int. 2021 Jul 17. doi: 10.1111/tri.13975.
    PubMed     Abstract available

  23. MCDONALD MF, Barrett SC, Malik TH, Anand A, et al
    Elevated Serum Sodium in Recipients of Liver Transplantation Has a Substantial Impact on Outcomes.
    Transpl Int. 2021 Jul 4. doi: 10.1111/tri.13968.
    PubMed     Abstract available

  24. GROTTENTHALER JM, Fuger JK, Mahling M, Konigsrainer A, et al
    Dynamics of glucose metabolism after liver transplantation: Prediabetes as a window of opportunity for patient survival and long-term kidney function.
    Transpl Int. 2021 Jul 2. doi: 10.1111/tri.13967.
    PubMed     Abstract available

    June 2021
  25. AL-KURD A, Kitajima T, Delvecchio K, Shamaa MT, et al
    Short recipient warm ischemia time improves outcomes in deceased donor liver transplantation.
    Transpl Int. 2021 Jun 25. doi: 10.1111/tri.13962.
    PubMed     Abstract available

  26. EMAMAULLEE J, Conrad C, Kim M, Goldbeck C, et al
    Assessment of the Global Practice of Living Donor Liver Transplantation.
    Transpl Int. 2021 Jun 24. doi: 10.1111/tri.13960.
    PubMed     Abstract available

  27. AMYGDALOS I, Bednarsch J, Meister FA, Erren D, et al
    Clinical value and limitations of the preoperative C-reactive-protein-to-albumin ratio in predicting postoperative morbidity and mortality after deceased-donor liver transplantation: a retrospective single-centre study.
    Transpl Int. 2021 Jun 22. doi: 10.1111/tri.13957.
    PubMed     Abstract available

  28. LAUTERIO A, De Carlis R, Valsecchi M, Vella I, et al
    Liver transplantation during the COVID-19 pandemic: a 2020 year-end report from Lombardy, northern Italy.
    Transpl Int. 2021 Jun 18. doi: 10.1111/tri.13953.
    PubMed     Abstract available

  29. CUSUMANO C, De Carlis L, Centonze L, Lesourd R, et al
    Advanced donor age does not increase risk of hepatocellular carcinoma recurrence after liver transplantation: a retrospective two-center analysis using competing risk analysis.
    Transpl Int. 2021 Jun 18. doi: 10.1111/tri.13950.
    PubMed     Abstract available

  30. HANN A, Sneiders D, Hartog H, Perera MTPR, et al
    Commentary on: Short recipient warm ischemia time improves outcomes in deceased donor liver transplantation.
    Transpl Int. 2021 Jun 18. doi: 10.1111/tri.13949.
    PubMed     Abstract available

  31. CAMPOS-VARELA I, Len O, Villagrasa A, Marquez-Algaba E, et al
    Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort.
    Transpl Int. 2021 Jun 14. doi: 10.1111/tri.13946.
    PubMed     Abstract available

    May 2021
  32. VISSEREN T, Erler NS, Polak WG, Adam R, et al
    Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond.
    Transpl Int. 2021 May 24. doi: 10.1111/tri.13925.
    PubMed     Abstract available

  33. UCHIDA H, Sakamoto S, Kasahara M, Ueno Y, et al
    An analysis of the outcomes in living donor liver transplantation for pediatric malignant hepatic tumors using nationwide survey data in Japan.
    Transpl Int. 2021 May 22. doi: 10.1111/tri.13924.
    PubMed     Abstract available

  34. D'AMICO G, Matsushima H, Diago Uso T, Armanyous SR, et al
    Long Term Outcomes and Complications of Reno-portal Anastomosis in Liver Transplantation: Results from a Propensity Score-Based Outcome Analysis.
    Transpl Int. 2021 May 18. doi: 10.1111/tri.13920.
    PubMed     Abstract available

  35. PASSAMONTI SM, Cannavo A, Panigada M, Trunzo V, et al
    Donation after circulatory death (DCD) and liver transplantation: a cohort study.
    Transpl Int. 2021 May 18. doi: 10.1111/tri.13919.
    PubMed     Abstract available

  36. IVANICS T, Shwaartz C, Claasen MPAW, Patel MS, et al
    Trends in Indications and Outcomes of Liver Transplantation in Canada: A Multi Centre Retrospective Study.
    Transpl Int. 2021 May 11. doi: 10.1111/tri.13903.
    PubMed     Abstract available

  37. NITTA H, Younes A, El-Domiaty N, Karam V, et al
    High Trough Levels of Everolimus Combined to Sorafenib Improve Patients Survival After Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients.
    Transpl Int. 2021 May 1. doi: 10.1111/tri.13897.
    PubMed     Abstract available

  38. LAROCHE S, Maulat C, Kitano Y, Golse N, et al
    Initial piggyback technique facilitates late liver retransplantation - a retrospective monocentric study.
    Transpl Int. 2021;34:835-843.
    PubMed     Abstract available

    April 2021
  39. HO OTW, Ng WCA, Ow ZGW, Ho YJ, et al
    Bisphosphonate Therapy after Liver Transplant Improves Bone Mineral Density and Reduces Fracture Rates: An Updated Systematic-Review and Meta-Analysis.
    Transpl Int. 2021 Apr 21. doi: 10.1111/tri.13887.
    PubMed     Abstract available

  40. KELLY WU W, Ziogas IA, Izzy M, Pai AK, et al
    Liver transplantation for congenital hepatic fibrosis.
    Transpl Int. 2021 Apr 20. doi: 10.1111/tri.13884.
    PubMed     Abstract available

  41. LIM WH, Ng CH, Ow ZGW, Ho OTW, et al
    A Systematic Review and Meta-Analysis on the Incidence of Osteoporosis and Fractures after Liver Transplant.
    Transpl Int. 2021 Apr 9. doi: 10.1111/tri.13863.
    PubMed     Abstract available

  42. LEE SA, Hyun J, Yoon YI, Park SY, et al
    Clinical Impact of Mild to Moderate Pulmonary Hypertension in Living-Donor Liver Transplantation.
    Transpl Int. 2021 Apr 2. doi: 10.1111/tri.13875.
    PubMed     Abstract available

  43. LECLAIRE JM, Smith NJ, Chandratre S, Rein L, et al
    Solid organ donor-recipient race-matching: analysis of the United Network for Organ Sharing database.
    Transpl Int. 2021;34:640-647.
    PubMed     Abstract available

    March 2021
  44. MOLINARI M, Carrillo CF, Dongling D, Jorgensen D, et al
    Portal Vein Thrombosis and Renal Dysfunction: A National Comparative Study of Liver Transplant Recipients for NAFLD versus Alcoholic Cirrhosis.
    Transpl Int. 2021 Mar 29. doi: 10.1111/tri.13873.
    PubMed     Abstract available

  45. OZEN J, Beime J, Brinkert F, Fischer L, et al
    Short- and long-term results of liver transplantation according to age at transplant: a single center experience of 351 children.
    Transpl Int. 2021 Mar 27. doi: 10.1111/tri.13872.
    PubMed     Abstract available

  46. CANTU P, Santi G, Rosa R, Parzanese I, et al
    Cost analysis of a long-term randomized controlled study in biliary duct-to-duct anastomotic stricture after liver transplantation.
    Transpl Int. 2021 Mar 17. doi: 10.1111/tri.13867.
    PubMed     Abstract available

  47. LOZANOVSKI VJ, Probst P, Arefidoust A, Ramouz A, et al
    Prognostic role of the Donor Risk Index, the Eurotransplant Donor Risk Index and the Balance of Risk score on graft loss after liver transplantation.
    Transpl Int. 2021 Mar 16. doi: 10.1111/tri.13861.
    PubMed     Abstract available

  48. YOON YI, Song GW, Lee SG, Park GC, et al
    Safe Use of Right Lobe Living Donor Livers with Moderate Steatosis in Adult-to-adult Living Donor Liver Transplantation: A Retrospective Study.
    Transpl Int. 2021 Mar 4. doi: 10.1111/tri.13859.
    PubMed     Abstract available

  49. MAZZOTTA AD, Pascale A, Cano L, Rosmorduc O, et al
    Number Of HCC Nodules in Patients Listed for Liver Transplantation Within Alpha-Fetoprotein Score : a New Prognostic Risk Factor.
    Transpl Int. 2021 Mar 3. doi: 10.1111/tri.13858.
    PubMed     Abstract available

    February 2021
  50. AKAMATSU N, Hasegawa K, Egawa H, Ohdan H, et al
    Donor age (>/= 45 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation - a multicenter retrospective study.
    Transpl Int. 2021 Feb 24. doi: 10.1111/tri.13852.
    PubMed     Abstract available

  51. SASAKI K, Nair A, Firl DJ, McVey JC, et al
    Conditional Probability of Graft Survival in Liver Transplantation using Donation after Circulatory Death grafts - a retrospective study.
    Transpl Int. 2021 Feb 17. doi: 10.1111/tri.13846.
    PubMed     Abstract available

  52. GAMBATO M, Germani G, Perini B, Gringeri E, et al
    A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS-CoV-2 infection.
    Transpl Int. 2021 Feb 8. doi: 10.1111/tri.13842.
    PubMed     Abstract available

  53. ABDELAZIZ O, Osman AMA, Hosny KA, Emad-Eldin S, et al
    Management of Early Hepatic Artery Thrombosis following Living-Donor Liver Transplantation: Feasibility, Efficacy and Potential Risks of Endovascular Therapy in the First 48 Hours Post-Transplant.
    Transpl Int. 2021 Feb 4. doi: 10.1111/tri.13839.
    PubMed     Abstract available

  54. WANIS KN, Sarvet A, Ruffolo LI, Levstik MA, et al
    Estimating the effect of increasing utilization of living donor liver transplantation using observational data.
    Transpl Int. 2021 Feb 1. doi: 10.1111/tri.13835.
    PubMed     Abstract available

    January 2021
  55. SHALABY S, Taborelli M, Zanetto A, Ferrarese A, et al
    Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation.
    Transpl Int. 2021 Jan 25. doi: 10.1111/tri.13831.
    PubMed     Abstract available

  56. CHEN M, Chen Z, Lin X, Hong X, et al
    Application of Ischemia-Free Liver Transplantation Improves Prognosis of Patients with Steatotic Donor Livers.
    Transpl Int. 2021 Jan 23. doi: 10.1111/tri.13828.
    PubMed     Abstract available

  57. LOZANOVSKI VJ, Probst P, Ramouz A, Arefidoust A, et al
    Considering Extended Right Lobe grafts as major Extended Donor Criteria in liver transplantation is justified.
    Transpl Int. 2021 Jan 20. doi: 10.1111/tri.13824.
    PubMed     Abstract available

  58. RICHARDS JA, Randle LV, Butler MChir AJ, Martin JL, et al
    Pilot study of a non-invasive real-time optical backscatter probe in liver transplantation.
    Transpl Int. 2021 Jan 19. doi: 10.1111/tri.13823.
    PubMed     Abstract available

  59. MOURAD M, Lebosse F, Merle P, Levrero M, et al
    External validation of the French AFP model for HCC liver transplantation in a recent unicentric cohort.
    Transpl Int. 2021 Jan 15. doi: 10.1111/tri.13819.
    PubMed     Abstract available

  60. FERRARESE A, Sartori G, Orru G, Frigo AC, et al
    Machine Learning in Liver Transplantation: a tool for some unsolved questions?
    Transpl Int. 2021 Jan 11. doi: 10.1111/tri.13818.
    PubMed     Abstract available

  61. NAGAI S, Safwan M, Kitajima T, Yeddula S, et al
    Disease-Specific Waitlist Outcomes in Liver Transplantation.
    Transpl Int. 2021 Jan 10. doi: 10.1111/tri.13814.
    PubMed     Abstract available

  62. THOMPSON ER, Connelly C, Ali S, Sheerin NS, et al
    Cell therapy during machine perfusion.
    Transpl Int. 2021;34:49-58.
    PubMed     Abstract available

    December 2020
  63. WOO HY, Hong SK, Cho JH, Lee JM, et al
    Complications of Polytetrafluoroethylene Graft-Use in Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation: A Retrospective, Single-Center, Long-Term, Real-World Experience.
    Transpl Int. 2020 Dec 23. doi: 10.1111/tri.13807.
    PubMed     Abstract available

  64. SCHOENBERG MB, Ehmer U, Umgelter A, Bucher JN, et al
    Liver Transplantation versus Watchful-Waiting in Hepatocellular Carcinoma Patients with Complete Response to Bridging-Therapy.
    Transpl Int. 2020 Dec 23. doi: 10.1111/tri.13808.
    PubMed     Abstract available

  65. DI SANDRO S, Magistri P, Bagnardi V, Catellani B, et al
    The Covid-19 second wave risk and liver transplantation: lesson from the recent past and the unavoidable need of living donors.
    Transpl Int. 2020 Dec 18. doi: 10.1111/tri.13803.
    PubMed     Abstract available

  66. MA L, Li M, Zhang T, Xu JQ, et al
    Incidence of de novo autoimmune hepatitis in children and adolescents with increased autoantibodies after liver transplantation: a meta-analysis.
    Transpl Int. 2020 Dec 14. doi: 10.1111/tri.13801.
    PubMed     Abstract available

  67. VAN DEN EYNDE J, Achtergaele J, Fieuws S, Jochmans I, et al
    The effect of organ preservation solutions on short-term outcomes after liver transplantation: a single-centre retrospective study.
    Transpl Int. 2020 Dec 6. doi: 10.1111/tri.13799.
    PubMed     Abstract available

  68. POLAK WG, Fondevila C, Karam V, Adam R, et al
    Reply to Rodriguez-Peralvarez et al.
    Transpl Int. 2020;33:1825-1826.

  69. MANGIONI D, Dondossola D, Antonelli B, Alagna L, et al
    Coronavirus disease 2019 and transplantation: tackling the challenges of SARS-CoV-2 infection in waiting list candidates.
    Transpl Int. 2020;33:1830-1832.

    November 2020
  70. RAUT V, Sonavane A, Shah K, Amruthraj C, et al
    Successful liver transplantation immediately after recovery from COVID-19 in a highly endemic area.
    Transpl Int. 2020 Nov 30. doi: 10.1111/tri.13790.
    PubMed     Abstract available

  71. RHU J, Kim JM, Jeong WK, Choi GS, et al
    Venous outflow congestion is related to poor recurrence-free survival of living donor liver transplantation recipients with hepatocellular carcinoma.
    Transpl Int. 2020 Nov 30. doi: 10.1111/tri.13792.
    PubMed     Abstract available

  72. NAVEZ J, Iesari S, Kourta D, Baami-Mariza K, et al
    The real incidence of biliary tract complications after adult liver transplantation: the role of the prospective routine use of cholangiography during post-transplant follow-up.
    Transpl Int. 2020 Nov 14. doi: 10.1111/tri.13786.
    PubMed     Abstract available

  73. NAM NH, Taura K, Yao S, Kaido T, et al
    Pretransplantation splenomegaly frequently persists after liver transplantation and can manifest as hypersplenism and graft fibrosis - a retrospective study.
    Transpl Int. 2020 Nov 9. doi: 10.1111/tri.13761.
    PubMed     Abstract available

  74. VISSEREN T, Fuhler GM, Erler NS, Nossent YRA, et al
    Recurrence of primary sclerosing cholangitis after liver transplantation is associated with specific changes in the gut microbiome pretransplant - a pilot study.
    Transpl Int. 2020;33:1424-1436.
    PubMed     Abstract available

    October 2020
  75. MEMARAN N, Kupper C, Borchert-Morlins B, von Wick A, et al
    Prospective Assessment of Subclinical Cardiovascular Damage and Associated Factors in Liver Transplant Recipients.
    Transpl Int. 2020 Oct 18. doi: 10.1111/tri.13773.
    PubMed     Abstract available

  76. IZZY M, Angirekula M, Bentall A, Plevak M, et al
    Role Of Symmetric Dimethylarginine In Predicting Future Renal Impairment In Liver Transplant Recipients.
    Transpl Int. 2020 Oct 17. doi: 10.1111/tri.13771.
    PubMed     Abstract available

  77. BRUGGENWIRTH IMA, van Reeven M, Vasiliauskaite I, van der Helm D, et al
    Donor diabetes mellitus is a risk factor for diminished outcome after liver transplantation: a nationwide retrospective cohort study.
    Transpl Int. 2020 Oct 17. doi: 10.1111/tri.13770.
    PubMed     Abstract available

  78. PINERO F, Anders M, Boin IF, Chagas A, et al
    Liver transplantation for hepatocellular carcinoma: impact of expansion criteria in a multicenter cohort study from a high waitlist mortality region."
    Transpl Int. 2020 Oct 11. doi: 10.1111/tri.13767.
    PubMed     Abstract available

  79. DE CARLIS R, Buscemi V, Checchini G, Frassoni S, et al
    Liver transplantation from brain-dead donors on mechanical circulatory support: a systematic review of the literature.
    Transpl Int. 2020 Oct 9. doi: 10.1111/tri.13766.
    PubMed     Abstract available

  80. MELANDRO F, Ghinolfi D, Balzano E, Tincani G, et al
    Light at the end of the tunnel: COVID-19 lockdown has not halted liver transplantation at a high volume center in Italy.
    Transpl Int. 2020 Oct 8. doi: 10.1111/tri.13764.
    PubMed     Abstract available

  81. KOVANDOVA B, Slavcev A, Honsova E, Erhartova D, et al
    De Novo HLA Class II Antibodies Are Associated with the Development of Chronic but not Acute Antibody-Mediated Rejection after Liver Transplantation.
    Transpl Int. 2020 Oct 5. doi: 10.1111/tri.13763.
    PubMed     Abstract available

  82. BOFFINI M, Pidello S, Simonato E, Barbero C, et al
    An effective protocol for heart transplantation during COVID-19 outbreak.
    Transpl Int. 2020;33:1326-1328.

    September 2020
  83. CHOI D, Liu M, Guttikonda D, Galen K, et al
    Recipient Risk Factors for Acute Cellular Rejection After Orthotopic Liver Transplant.
    Transpl Int. 2020 Sep 29. doi: 10.1111/tri.13756.
    PubMed     Abstract available

  84. IMAOKA Y, Ohira M, Sato K, Kuroda S, et al
    Impact of Donor Abdominal Aortic Calcification among Living Donor Liver Transplant Donors: A Retrospective Study.
    Transpl Int. 2020 Sep 24. doi: 10.1111/tri.13748.
    PubMed     Abstract available

  85. LEVI SANDRI GB, Berardi G, Giannelli V, Ettorre GM, et al
    Primary role of Radioembolization as a downstaging strategy in patients with macrovascular invasion prior to liver transplantation.
    Transpl Int. 2020 Sep 15. doi: 10.1111/tri.13746.
    PubMed     Abstract available

  86. MAHALE P, Mckenna GJ, Saracino G, Jennings L, et al
    Hypomagnesemia and risk of post-transplant lymphoproliferative disorder in liver transplant recipients.
    Transpl Int. 2020 Sep 7. doi: 10.1111/tri.13735.
    PubMed     Abstract available

  87. RODRIGUEZ-PERALVAREZ M, Salcedo M, Colmenero J, Pons JA, et al
    Increased incidence of Covid-19 among liver transplant patients in Europe.
    Transpl Int. 2020 Sep 2. doi: 10.1111/tri.13729.
    PubMed     Abstract available

  88. PASCALE MM, Bianco G, Ferri L, Agnes S, et al
    COVID-19 health restrictions in a transplanted Italian cohort.
    Transpl Int. 2020;33:1151-1153.

  89. SHI H, Xu J, Li X, Zhao Y, et al
    First organ donation in Wuhan after ending of the coronavirus lockdown.
    Transpl Int. 2020;33:1149-1150.

    August 2020
  90. WIJARNPREECHA K, Pungpapong S, Aby ES, Croome KP, et al
    Simultaneous liver transplant and sleeve gastrectomy not associated with worse index admission outcomes compared to liver transplant alone.
    Transpl Int. 2020 Aug 9. doi: 10.1111/tri.13713.
    PubMed     Abstract available

  91. LERUT J, Karam V, Cailliez V, Bismuth H, et al
    What did the European Liver Transplant Registry (ELTR) Bring to Liver Transplantation?
    Transpl Int. 2020 Aug 7. doi: 10.1111/tri.13716.
    PubMed     Abstract available

    July 2020
  92. PRAVISANI R, Hidaka M, Baccarani U, Ono S, et al
    Effect of pre-transplant sarcopenia on the estimation of standard liver volume in living-donor liver transplant candidates: risk factor for post-transplant small for size syndrome?
    Transpl Int. 2020 Jul 4. doi: 10.1111/tri.13690.
    PubMed     Abstract available

  93. POLAK WG, Fondevila C, Karam V, Adam R, et al
    Impact of COVID-19 on liver transplantation in Europe: Alert from an early survey of European Liver and Intestine Transplantation Association (ELITA) and European Liver Transplant Registry (ELTR).
    Transpl Int. 2020 Jul 1. doi: 10.1111/tri.13680.
    PubMed     Abstract available

    June 2020
  94. LEVESQUE E, Lim C, Feray C, Salloum C, et al
    Liver Transplantation in Patients with Sickle Cell Disease: possible but challenging.
    Transpl Int. 2020 Jun 7. doi: 10.1111/tri.13669.
    PubMed     Abstract available

    April 2020
  95. LAUTERIO A, De Carlis R, Belli L, Fumagalli R, et al
    How to guarantee liver transplantation in the north of Italy during the COVID-19 pandemic. A sound transplant protection strategy.
    Transpl Int. 2020 Apr 29. doi: 10.1111/tri.13633.
    PubMed     Abstract available

  96. WERNER JM, Hornung M, Krah R, Gotz M, et al
    HCC recurrence in HCV patients after liver transplantation: SiLVER Study reveals benefits of sirolimus in combination with CNIs.
    Transpl Int. 2020 Apr 21. doi: 10.1111/tri.13621.
    PubMed     Abstract available

  97. ISMAIL MS, Hassan M, Martinez-Camacho A, May SB, et al
    Retrospective analysis of long-term outcome 10 years after liver transplantation for Wilson disease: experience over three decades.
    Transpl Int. 2020 Apr 21. doi: 10.1111/tri.13622.
    PubMed     Abstract available

  98. HESSHEIMER AJ, Gastaca M, Minambres E, Colmenero J, et al
    Donation after circulatory death liver transplantation: consensus statements from the spanish liver transplantation society.
    Transpl Int. 2020 Apr 20. doi: 10.1111/tri.13619.
    PubMed     Abstract available

    January 2020
  99. ASSALINO M, Terraz S, Grat M, Lai Q, et al
    Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion.
    Transpl Int. 2020 Jan 28. doi: 10.1111/tri.13586.
    PubMed     Abstract available

  100. AL-AMERI AAM, Wei X, Wen X, Wei Q, et al
    Systematic Review: Risk Prediction Models for Recurrence of Hepatocellular Carcinoma after Liver Transplantation.
    Transpl Int. 2020 Jan 27. doi: 10.1111/tri.13585.
    PubMed     Abstract available

    December 2019
  101. LAW JH, Tan NCH, Kow AWC
    Letter to Editor - Initial Experience of Laparoscopic Living Donor Hepatectomy for Pediatric Liver Transplantation in a Southeast Asian Transplant Center.
    Transpl Int. 2019 Dec 23. doi: 10.1111/tri.13565.
    PubMed     Abstract available

    October 2019
  102. YAZAWA M, Cseprekal O, Helmick RA, Talwar M, et al
    Association Between Post-Transplant Donor Specific Antibodies and Recipient Outcomes in Simultaneous Liver-Kidney Transplant Recipients: single center, cohort study.
    Transpl Int. 2019 Oct 24. doi: 10.1111/tri.13543.
    PubMed     Abstract available

    September 2019
  103. LAUTERIO A, De Carlis R, Di Sandro S, Buscemi V, et al
    Delayed kidney transplantation in combined liver-kidney transplantation for polycystic liver and kidney disease.
    Transpl Int. 2019 Sep 27. doi: 10.1111/tri.13537.
    PubMed     Abstract available

    June 2019
  104. HILLEBRANDT KH, Everwien H, Haep N, Keshi E, et al
    Strategies based on organ decellularization and recellularization.
    Transpl Int. 2019;32:571-585.
    PubMed     Abstract available

  105. WEISSENBACHER A, Vrakas G, Nasralla D, Ceresa CDL, et al
    The future of organ perfusion and re-conditioning.
    Transpl Int. 2019;32:586-597.
    PubMed     Abstract available

    April 2019
  106. MINNEE RC, Darwish Murad S, Polak WG, Metselaar HJ, et al
    Combined liver-kidney transplantation; two for the price of one?
    Transpl Int. 2019 Apr 8. doi: 10.1111/tri.13438.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.